Literature DB >> 21326931

The monoclonal myth.

Thomas C Scanlon1, Heather L Jewell, Elizabeth C Gray, Karl E Griswold.   

Abstract

Most researchers confidently assume that transformation of recombinant plasmid libraries into microbial hosts followed by outgrowth of isolated colonies results in a "one cell-one mutant gene-one protein variant" paradigm. Indeed, this assumption is supported by the overwhelming majority of published studies employing bacterial expression hosts. In stark contrast, we recently reported on Saccharomyces cerevisiae libraries containing unexpectedly high frequencies of cells harboring heterogeneous mixtures of plasmids, so called Multiple Vector Transformants (MVT). Intriguingly, we observed that yeast MVT persist as a significant proportion of populations for multiple generations. MVT can lead to misidentification of isolated mutants loss of functionally enhanced clones, and unwitting propagation of false positives derived from contaminating control sequences. Such experimental complications can have devastating outcomes in the context of protein engineering by combinatorial library screening. Herein, we demonstrate that the phenomenon of MVT is not restricted to vectors bearing the CEN/ARSH origin of replication, but may be an even greater concern when using high copy 2 µm plasmids. To mitigate the risks associated with MVT, we have developed an optimized sequencing procedure that facilitates rapid and reliable identification of MVT among clones of interest. In our experience, MVT and their associated risks can be virtually eliminated by employing extended liquid outgrowths of transformed populations and archiving sequence-verified, monoclonal, mutant genes from cell-templated PCR amplicons.
© 2010 Landes Bioscience

Entities:  

Keywords:  combinatorial library construction; high efficiency transformation; multiple vector transformants; protein engineering; yeast plasmids

Mesh:

Year:  2010        PMID: 21326931      PMCID: PMC3026430          DOI: 10.4161/bbug.1.3.11724

Source DB:  PubMed          Journal:  Bioeng Bugs        ISSN: 1949-1018


  11 in total

1.  Retraction. Directed evolution of new catalytic activity using the alpha/beta-barrel scaffold.

Authors:  M M Altamirano; J M Blackburn; C Aguayo; A R Fersht
Journal:  Nature       Date:  2002-05-23       Impact factor: 49.962

2.  Retraction. Fluorobodies combine GFP fluorescence with the binding characteristics of antibodies.

Authors:  Ahmet Zeytun; Andreas Jeromin; Bethe A Scalettar; Geoffrey S Waldo; Andrew R M Bradbury
Journal:  Nat Biotechnol       Date:  2004-05       Impact factor: 54.908

Review 3.  Miniaturising the laboratory in emulsion droplets.

Authors:  Andrew D Griffiths; Dan S Tawfik
Journal:  Trends Biotechnol       Date:  2006-07-14       Impact factor: 19.536

4.  Ribosome display: selecting and evolving proteins in vitro that specifically bind to a target.

Authors:  Christian Zahnd; Patrick Amstutz; Andreas Plückthun
Journal:  Nat Methods       Date:  2007-03       Impact factor: 28.547

5.  Plasmid incompatibility: more compatible than previously thought?

Authors:  Nileena Velappan; Daniele Sblattero; Leslie Chasteen; Peter Pavlik; Andrew R M Bradbury
Journal:  Protein Eng Des Sel       Date:  2007-03-01       Impact factor: 1.650

6.  Avoiding and controlling double transformation artifacts.

Authors:  Moshe Goldsmith; Csaba Kiss; Andrew R M Bradbury; Dan S Tawfik
Journal:  Protein Eng Des Sel       Date:  2007-06-15       Impact factor: 1.650

7.  Retraction.

Authors:  Mary A Dwyer; Loren L Looger; Homme W Hellinga
Journal:  Science       Date:  2008-02-01       Impact factor: 47.728

Review 8.  Determination of plasmid copy number in yeast.

Authors:  B E Jordan; R C Mount; C Hadfield
Journal:  Methods Mol Biol       Date:  1996

9.  Regulatable promoters of Saccharomyces cerevisiae: comparison of transcriptional activity and their use for heterologous expression.

Authors:  D Mumberg; R Müller; M Funk
Journal:  Nucleic Acids Res       Date:  1994-12-25       Impact factor: 16.971

10.  Quantifying and resolving multiple vector transformants in S. cerevisiae plasmid libraries.

Authors:  Thomas C Scanlon; Elizabeth C Gray; Karl E Griswold
Journal:  BMC Biotechnol       Date:  2009-11-20       Impact factor: 2.563

View more
  1 in total

1.  Genetically enhanced lysozyme evades a pathogen derived inhibitory protein.

Authors:  Sarah M Dostal; Yongliang Fang; Jonathan C Guerrette; Thomas C Scanlon; Karl E Griswold
Journal:  ACS Chem Biol       Date:  2015-01-30       Impact factor: 5.100

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.